Irras AB is Sweden- based medical device company primarily engaged in develops and commercializes solutions that are designed to transform neurocritical care. Company focus on neurosurgical procedures, where excess cerebrospinal fluid (CSF) or toxic blood byproducts often need to be emergently drained and intracranial pressure (ICP) needs to be closely regulated.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Closed - Nasdaq Stockholm 11:59:43 03/11/2023 GMT			5-day change	1st Jan Change
0.1604 ^SEK	-1.11%		-.--%	-

27/06/25	IRRAS AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/06/24	IRRAS AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Market Cap	182M 18.59M 16.11M 15.22M 13.82M 25.9M 1.78B 26.06M 70.23M 904M 69.82M 68.27M 2.88B	P/E 2023	-0.73x	P/E 2024	-1.89x
Enterprise Value	396M 40.45M 35.05M 33.13M 30.08M 56.37M 3.88B 56.71M 153M 1.97B 152M 149M 6.27B	EV / Sales 2023	5.26x	EV / Sales 2024	6.82x
Free-Float	3.55%	Yield 2023 *	-	Yield 2024	-

27/06/25	IRRAS AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/06/24	IRRAS AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03/11/23	Irras has today its last day of trading on Nasdaq Stockholm before delisting	FW
24/10/23	IRRAS AB(OM:IRRAS) dropped from OMX Nordic All-Share Index	CI
24/10/23	IRRAS AB(OM:IRRAS) dropped from OMX Nordic Small Cap Index	CI
23/10/23	Irras Obtains Nasdaq Approval for Delisting in Stockholm	MT
20/10/23	Irras delisted from Nasdaq Stockholm with last trading day on November 3	FW
20/10/23	Sweden's Irras Files for Delisting as Privatization Nears Completion	MT
20/10/23	IR Holding Bidco calls for compulsory acquisition in Irras - applies for delisting	FW
16/10/23	Irras Obtains Extension for SEK20 Million Loan	MT
16/10/23	Irras extends SEK 20 million short-term loan	FW
02/10/23	Bidder controls 87.9 percent of the shares in Irras after completion of takeover bid	FW
19/09/23	Set-off issue only realistic option to avoid insolvency situation - Irra Board	FW

30/06/23	Bid for Irras below historical median premium - but also high risk of more fundraising - Afv(R)	FW
30/06/23	Bid for Irras below historical median premium - but also high risk of more fundraising - Afv	FW
22/05/23	Irra's Q1 sales below expectations - Redeye predicts new share issue and halves fair value	FW
22/05/23	Redeye lowers motivated value for Irras to SEK 0.15 (0.30)	FW
20/02/23	Redeye reiterates motivated value for Irras, but predicts capital raising this year	FW

IRRS ABNPV Share Price

Stocks

IRRAS

SE0008321202

Medical Equipment, Supplies & Distribution

Valuation: IRRS ABNPV

Latest news: IRRS ABNPV

Analysts' recommendations: IRRS ABNPV

Press Releases: IRRS ABNPV

Quotes and Performance

Price Extremes

Managers and Directors: IRRS ABNPV

Medical Devices & Implants

Financials

Company Profile

20/10/23	IRRAS's application for delisting has been approved and the Board of Directors has resolved not to publish the interim report for the third quarter of 2023	AQ
19/10/23	NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB	AQ
19/10/23	IR Holding Bidco Inc. requests compulsory buy-out and IRRAS applies for delisting	AQ
16/10/23	IRRAS publishes prospectus	AQ
15/10/23	IRRAS has extended maturity date for its SEK 20 million short-term loan	AQ

Manager	Title	Age	Since
Will Martin CEO	Chief Executive Officer	51	30/06/2021
Griffen Stapp DFI	Director of Finance/CFO	40	16/06/2021
Sten Gustafsson IRC	Investor Relations Contact	-	08/03/2021

Director	Title	Age	Since
Kleanthis Xanthopoulos BRD	Director/Board Member	68	31/05/2015
Marios Fotiadis CHM	Chairman	53	17/08/2020
Inger Gunnel Anita Tollstadius BRD	Director/Board Member	71	31/08/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IRRS ABNPV	-1.11%	-.--%	-.--%	-9.43%	16.9M
STRYKER CORPORATION	+1.16%	+3.40%	-24.39%	-2.74%	108B
SMITH & NEPHEW PLC	+0.43%	+1.61%	-24.36%	-2.11%	11.77B
GLAUKOS CORPORATION	-4.78%	-9.08%	+98.51%	+117.61%	10.12B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.57%	-4.58%	-54.22%	-71.49%	3.97B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.25%	-5.64%	-29.26%	+21.67%	2.36B
INSPIRE MEDICAL SYSTEMS, INC.	-2.48%	+9.43%	-9.96%	-65.51%	2.16B
INSIGHT LIFETECH CO., LTD.	0.00%	-5.48%	-	-	1.82B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.19%	-3.04%	-21.91%	-30.15%	1.5B
Average	-0.70%	+0.10%	-8.20%	-5.27%	15.74B
Weighted average by Cap.	+0.55%	+2.13%	-16.17%	+3.23%

	2023	2024
Net sales	42.88M 4.39M 3.8M 3.59M 3.26M 6.11M 421M 6.15M 16.57M 213M 16.47M 16.11M 680M	57.98M 5.93M 5.14M 4.86M 4.41M 8.26M 569M 8.31M 22.41M 289M 22.28M 21.78M 920M
Net income	-209M -21.36M -18.51M -17.5M -15.88M -29.77M -2.05B -29.95M -80.71M -1.04B -80.24M -78.46M -3.31B	-95.98M -9.82M -8.51M -8.04M -7.3M -13.68M -942M -13.76M -37.09M -478M -36.87M -36.06M -1.52B
Net Debt	43.85M 4.48M 3.89M 3.67M 3.33M 6.25M 430M 6.29M 16.94M 218M 16.84M 16.47M 695M	214M 21.86M 18.95M 17.91M 16.26M 30.47M 2.1B 30.65M 82.61M 1.06B 82.13M 80.31M 3.39B

3 years	0.16	0.18
5 years	0.11	5.09
10 years	0.11	47